Type 2 Diabetes Trial, Not Yet Recruiting NCT06312553 Sponsor: University of Alabama at Birmingham Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT06312553
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 19 years or older
  • People who have been diagnosed with type 2 diabetes
  • People who identify as Black (self-reported)
  • People who receive their care at one of the study sites and have had at least one visit there in the past year
  • People who have a moderate to severe level of diabetes-related emotional distress, based on a score of 2 or higher on a standard diabetes distress questionnaire
  • People whose diabetes is not well controlled, shown by a blood sugar measurement (called HbA1c) of 8% or higher

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who do not speak English
  • People who are currently pregnant
  • People who have been diagnosed with a serious mental health condition such as bipolar disorder, schizophrenia, or who have a history of psychosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Caroline A Presley, MD, MPH, University of Alabama at Birmingham

Phone: 205-934-7609

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
30 June 2027

Primary endpoints

Feasibility: percentage of screened participants who are eligible; Feasibility: percentage of eligible participants who enroll; Feasibility: ability to randomize participants to study arms; Feasibility: distribution of participants by demographics; Feasibility: percentage of sessions attended; Feasibility: participant adherence to study tasks include home mindfulness practices, self-monitoring activities.; Feasibility: barriers to participation in intervention sessions or completing study activities at home; Feasibility: reasons for dropping out; Feasibility: overall study retention; Acceptabi...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov